Filing Details
- Accession Number:
- 0000905148-24-001625
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-24 16:07:59
- Reporting Period:
- 2024-05-22
- Accepted Time:
- 2024-05-24 16:07:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1228627 | Ocuphire Pharma Inc. | OCUP | Pharmaceutical Preparations (2834) | 113516358 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2008983 | Ashwath Jayagopal | C/O Ocuphire Pharma, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI 48335 | Chief Scientific & Dev. Ofc. | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-22 | 3,500 | $1.77 | 78,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
